- Home
- WTTR vs OPK Comparison
WTTR vs OPK Comparison
Compare WTTR & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- OPK
- Stock Information
- Founded
- WTTR 2016
- OPK 2007
- Country
- WTTR United States
- OPK United States
- Employees
- WTTR N/A
- OPK N/A
- Industry
- WTTR Oilfield Services/Equipment
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- OPK Health Care
- Exchange
- WTTR Nasdaq
- OPK Nasdaq
- Market Cap
- WTTR 922.1M
- OPK 1.0B
- IPO Year
- WTTR 2017
- OPK 1995
- Fundamental
- Price
- WTTR $8.41
- OPK $1.35
- Analyst Decision
- WTTR Strong Buy
- OPK Buy
- Analyst Count
- WTTR 3
- OPK 4
- Target Price
- WTTR $15.00
- OPK $2.75
- AVG Volume (30 Days)
- WTTR 979.2K
- OPK 2.0M
- Earning Date
- WTTR 11-04-2025
- OPK 11-06-2025
- Dividend Yield
- WTTR 3.34%
- OPK N/A
- EPS Growth
- WTTR N/A
- OPK N/A
- EPS
- WTTR 0.32
- OPK N/A
- Revenue
- WTTR $1,458,995,000.00
- OPK $664,029,000.00
- Revenue This Year
- WTTR N/A
- OPK N/A
- Revenue Next Year
- WTTR $0.71
- OPK $0.84
- P/E Ratio
- WTTR $26.03
- OPK N/A
- Revenue Growth
- WTTR N/A
- OPK N/A
- 52 Week Low
- WTTR $7.20
- OPK $1.11
- 52 Week High
- WTTR $15.14
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- WTTR 47.09
- OPK 47.95
- Support Level
- WTTR $8.29
- OPK $1.34
- Resistance Level
- WTTR $8.73
- OPK $1.39
- Average True Range (ATR)
- WTTR 0.27
- OPK 0.04
- MACD
- WTTR 0.07
- OPK -0.00
- Stochastic Oscillator
- WTTR 63.01
- OPK 11.11
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.